Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02388321 · ClinicalTrials.gov registry record · Phase 4
Pediatric Ketamine Study for Pain Management
A Phase 4 study, sponsored by Antonios Likourezos.
- Terminated
- Registry status
- Phase 4
- Development phase
- 22
- Enrollment target
NCT02388321 is a Phase 4 study that was terminated before completion, run by Antonios Likourezos. The registered enrollment target is 22 participants.
The verdict
NCT02388321, a Phase 4 study, was terminated before completion, sponsored by Antonios Likourezos.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 22 participants
- Enrollment target
Study Summary
Direct comparison of intranasal sub-dissociative dose ketamine with intranasal fentanyl for the treatment of moderate to severe pain in pediatric patients in the emergency department.
Interventions
- DRUG Ketamine
- DRUG Fentanyl
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2015-05-01 |
| Est. Completion | 2017-10-14 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02388321
The ClinicalTrials.gov registry entry for NCT02388321 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Antonios Likourezos, which has 33 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ketamine is the first listed.
NCT02388321 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02388321 about?
NCT02388321 is a clinical study titled "Pediatric Ketamine Study for Pain Management". Direct comparison of intranasal sub-dissociative dose ketamine with intranasal fentanyl for the treatment of moderate to severe pain in pediatric patients in the emergency department.
What is the current status of trial NCT02388321?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 22 participants. The study started on 2015-05-01. Estimated completion is 2017-10-14.
What interventions are being tested in trial NCT02388321?
The interventions under investigation include: Ketamine (DRUG), Fentanyl (DRUG).
Who is sponsoring clinical trial NCT02388321?
This trial is sponsored by Antonios Likourezos, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.